mRNA-based SARS-CoV-2 vaccination is associated with reduced ICU admission rate and disease severity in critically ill COVID-19 patients treated in Switzerland.

Authors :: Hilty MP
Keiser S
Wendel Garcia PD
Moser A
Schuepbach RA
Source :: Intensive care medicine [Intensive Care Med] 2022 Mar; Vol. 48 (3), pp. 362-365. Date of Electronic Publication: 2022 Jan 20.
Publication Year :: 2022

Subjects :: COVID-19 Vaccines
Critical Illness
Humans
Intensive Care Units
RNA, Messenger
Severity of Illness Index
Switzerland
Vaccination
COVID-19
SARS-CoV-2

Full Text Access

Tools